CLINICAL_TRIALS
trial_result
· 2021-06-18
Clinical Trial Update: Efficacy and Safety of Trans Sodium Crocetinate (TSC) for Treatment of Suspected Stroke [Phase 2]
Summary
Phase 2 trial update on Trans Sodium Crocetinate (TSC) for suspected acute stroke was terminated; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Diffusion Pharmaceuticals Inc | Conditions: Stroke, Acute | Phase 2 | Status: TERMINATED | Results posted: 2021-06-18